Similarly, mutations in ITGB1, ITGB3, and ITGB7 can alter their interaction with calpain, which may affect the focal adhesion of cancer cells and therefore needs to be validated further via a multidisciplinary approach. The gene discussed is ITGB3; the disease is cancer.